Who We Are - In New Zealand since 1962

The company is a wholly owned subsidiary of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. , Kenilworth, NJ, USA. In all markets apart from the United States and Canada, we are known as MSD.

MSD began trading in Wellington, New Zealand in 1962 and relocated its Human Health operation to Auckland in 1971.

Today MSD’s Auckland site focuses on clinical research and supply of a portfolio of prescription only medicines for a wide range of diseases.

MSD New Zealand supplies pharmaceuticals and vaccines for New Zealand patients across a broad number of therapeutic areas, including; oncology, anaesthesia, vaccinology, HIV/AIDS, antibacterials and antifungals.

New Zealand research and development

MSD is a leader in New Zealand research and development, invests heavily in New Zealand and has consistently championed local research.

MSD Gives Back

MSD is proud to offer a global employee volunteerism policy which provides each employee with the opportunity to take up to 40 hours of paid leave each year, to engage in a variety of charity volunteer opportunities.


MSD works in partnership with a number of not-for-profit organisations that represent the interests and views of healthcare consumers. These organisations provide support services and information to patients, families and carers.

Fellowship for Global Human Health

The MSD Fellowship for Global Health is a three-month, field-based pro bono programme designed to leverage the skills and talents of our employees. It pairs the best minds from the company with non-profit partner organisations around the world, to provide meaningful and systematic improvements in health service delivery for people in greatest need.